Solicitation for Applications for Medicare Prescription Drug Plan 2017 Contracts (CMS-10137)

ICR 201509-0938-014

OMB: 0938-0936

Federal Form Document

ICR Details
0938-0936 201509-0938-014
Historical Active 201409-0938-015
HHS/CMS
Solicitation for Applications for Medicare Prescription Drug Plan 2017 Contracts (CMS-10137)
Revision of a currently approved collection   No
Regular
Approved with change 05/09/2016
Retrieve Notice of Action (NOA) 09/30/2015
Previous terms continue: This ICR is approved for 12 months as it is associated with CMS's annual "Call Letter." Since the Call Letter discusses the information to be contained in the applications and the method by which they shall be submitted to CMS, in the Call Letter CMS shall (a) provide a reference to this OMB control number whenever the Part D application requirements are discussed, (b) provide an estimate of the burden entailed, and (c) indicate that CMS has issued a 60 day Federal Register notice for this ICR inviting public comments on the burden estimates and utility associated with this collection. CMS shall ensure that enough time is provided to the public to allow for both the 60 day and 30 day public comment periods. Per the PRA, OMB approval must be secured prior to the date by which Medicare Part D plans will need to submit these applications. The timing of the Call Letter and the 60 day and 30 day Federal Register notices should therefore be carefully considered and coordinated. Consistent with the PRA, this ICR should be re-submitted along with the publication of the draft "forthcoming guidance" documents to the extent the guidance document will result in new information collection, recordkeeping, or disclosure requirements or result in changes to burden or capital costs from existing requirements.
  Inventory as of this Action Requested Previously Approved
05/31/2017 36 Months From Approved 11/30/2017
230 0 239
2,109 0 2,193
0 0 0

The Applications for Part D sponsors to offer qualified prescription drug coverage are completed by entities seeking approval to offer Part D benefits under the Medicare Prescription Drug Benefit program established by section 101 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) and is codified in section 1860D of the Social Security Act (the Act).

Statute at Large: 18 Stat. 1860 Name of Statute: null
   PL: Pub.L. 111 - 148 3310 Name of Law: Reducing Wasteful dispensing of outpatient drugs in LTC facilities
   PL: Pub.L. 111 - 148 3314 Name of Law: Including cost incurred by AIDS drug assistance programs and Indian Health services
   PL: Pub.L. 108 - 173 1860D Name of Law: Medicare Prescription Drug Benefit Program
   PL: Pub.L. 111 - 148 6005 Name of Law: Pharmacy benefit managers transparency requirements
  
None

Not associated with rulemaking

  80 FR 38692 07/07/2015
80 FR 57616 09/24/2015
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 230 239 0 0 -9 0
Annual Time Burden (Hours) 2,109 2,193 0 0 -84 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
We have adjusted our cost estimates by using the most recent BLS wage estimates. Overall, the estimated hour burden for completion of the prescription drug applications is 2,109 hours. This is an 84 hour decrease from the 2016 prescription drug application. Based on prior years' experience CMS has determined that the estimated the number of 2017 applicants should be adjusted by -9 to properly reflect the decrease in MAPD organizations seeking to apply to contract with CMS. Specifically, CMS estimates that for 2017 there will be as many applications as were actually received for 2016, and the majority of those received will be expansions of existing contracts, which require 60% fewer hours to complete. The overall paperwork burden is decreased for PDP, MA-PD, Cost Plan, PACE, EGWP Plan, and SAE applicants because of the decrease in the estimated number of applicants. The burden per applicant has increased slightly for initial applicants because of the addition of one to three attestations, depending on application type.

$140,000
No
No
Yes
No
No
Uncollected
Mitch Bryman 410 786-5258 Mitch.Bryman@cms.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/30/2015


© 2025 OMB.report | Privacy Policy